BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2149458)

  • 1. Initial treatment of prostatic cancer by endocrine measures and cytotoxic drugs.
    Tunn UW; Goldschmidt AJ; Peter K; Becker M
    Prog Clin Biol Res; 1990; 359():165-76; discussion 177-80. PubMed ID: 2149458
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chemotherapy of advanced prostate cancer].
    Hofmann W; Langkopf B
    Z Urol Nephrol; 1986 Jan; 79(1):33-9. PubMed ID: 2938361
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment results of combined hormone and chemotherapy in patients with advanced prostate cancer].
    Uekado Y
    Hinyokika Kiyo; 1991 Aug; 37(8):825-31. PubMed ID: 1957724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy of prostatic cancer with cyproterone acetate].
    Maier U
    Wien Klin Wochenschr; 1988 Jan; 100(1):16-9. PubMed ID: 2964127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical evaluation of chemohormonal therapy as an initial treatment for stage D2 prostatic cancer--effect of UFT administration combined with hormonal therapy].
    Honda M; Takasaki E; Suzuki T; Maeda S; Imai T; Hosoya Y; Chen JA
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):105-9. PubMed ID: 7826063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone chemotherapy for newly diagnosed patients with metastatic prostate cancer.
    Kubota Y; Nakada T; Suzuki Y; Iizima Y; Adachi Y; Hashimoto T
    Int Urol Nephrol; 1993; 25(5):469-74. PubMed ID: 8270375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the LHRH analogue zoladex depot alone and in combination with cyproterone acetate in the treatment of advanced prostatic cancer.
    Di Silverio F; Serio M; Costantini A
    J Chemother; 1989 Jul; 1(4 Suppl):1231-4. PubMed ID: 16312846
    [No Abstract]   [Full Text] [Related]  

  • 8. The case for early combined hormonal and cytostatic treatment for metastatic prostatic carcinoma.
    Servadio C
    Prog Clin Biol Res; 1987; 243B():449-53. PubMed ID: 3659039
    [No Abstract]   [Full Text] [Related]  

  • 9. Fifteen years' experience of combined hormone/chemotherapy in metastatic prostate cancer.
    Servadio C; Mukamel E; Nussbaum B
    Urology; 1992 Mar; 39(3):274-6. PubMed ID: 1532103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of virginal prostatic cancer with cyproterone acetate].
    Maier U
    Z Urol Nephrol; 1985 Apr; 78(4):181-7. PubMed ID: 3160180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combination therapy with hormonal, radiation and chemotherapy for stage C prostate cancer].
    Iwasawa T; Matsumoto H
    Hinyokika Kiyo; 1996 Nov; 42(11):869-74. PubMed ID: 8973937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: The combination of cyproterone acetate and low dose diethylstilbestrol in the treatment of advanced prostatic carcinoma.
    Varenhorst E; Wallentin L
    J Urol; 1989 Nov; 142(5):1335-6. PubMed ID: 2530361
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of combination chemotherapy with etoposide, ifosfamide, peplomycin for advanced prostatic cancer].
    Ushiyama T; Ihara H; Kurita Y; Kageyama S; Ueda D; Mugiya S; Yamaguchi Y; Nakano M; Suzuki K; Kawabe K
    Hinyokika Kiyo; 1993 Dec; 39(12):1139-44. PubMed ID: 8285162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of poor prognostic patients with advanced prostatic carcinoma with the association of diethylstilbestrol and cyclophosphamide.
    Germá Lluch JR; Marcuello Gaspar E; de Andrés Basauri L; López Pousa A; López López JJ
    Rev Esp Oncol; 1982; 29(2):317-24. PubMed ID: 7188232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of prostatic cancer with cyproterone acetate as monotherapy.
    Beurton D; Grall J; Davody P; Cukier J
    Prog Clin Biol Res; 1987; 243A():369-77. PubMed ID: 2958861
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cyproterone acetate and cancer of the prostate. Experience in 46 cases].
    Tauveron I; Hermabessière J
    Therapie; 1988 May; 43(3):175-7. PubMed ID: 2971277
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of advanced cancer of the prostate using LHRH analogs. How can a possible initial flare-up be prevented?].
    Bouffioux C; Denis L; Mahler C; de Leval J
    Acta Urol Belg; 1986; 54(3):304-8. PubMed ID: 2946208
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemotherapy of hormonally unresponsive prostatic carcinoma.
    deKernion JB; Lindner A
    Urol Clin North Am; 1984 May; 11(2):319-26. PubMed ID: 6233779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combined hormone and chemotherapy for the patients with advanced prostate cancer].
    Uekado Y; Hirano A; Inagaki T; Hiroi A; Watanabe T
    Gan To Kagaku Ryoho; 1995 Jul; 22(8):1041-5. PubMed ID: 7611755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic agents effective in prostate cancer.
    Schmidt JD
    Semin Urol; 1983 Nov; 1(4):299-310. PubMed ID: 6399616
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.